NCT03155139View on ClinicalTrials.gov

Primary Aldosteronism In Hypertensive Patients in China

CompletedOBSERVATIONAL
Enrollment

3,500

Participants

Timeline

Start Date

June 3, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Hyperaldosteronism; PrimaryHypertension Secondary
Interventions
DIAGNOSTIC_TEST

Aldosterone/renin ratio (ARR) testing

Plasma aldosterone concentration tests, Direct renin concentration tests

DIAGNOSTIC_TEST

Confirmatory tests

Captopril challenge test, Saline infusion test

Trial Locations (1)

400016

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
collaborator

Fu Wai Hospital, Beijing, China

OTHER

lead

Qifu Li

OTHER

NCT03155139 - Primary Aldosteronism In Hypertensive Patients in China | Biotech Hunter | Biotech Hunter